Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000102909-25-000136·HERON THERAPEUTICS, INC. /DE/
Schedule 13G ownership disclosure
HERON THERAPEUTICS, INC.
Common Stock · CUSIP: 427746102
Event date: 2025-09-30
- Filing-level shares
- 8,459,784
- Percent of class
- 4.61%
- The Vanguard Group
Shares: 8,459,784 · Class: 4.61%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-25-000136
- Form type
- SCHEDULE 13G/A
- Filer
- HERON THERAPEUTICS, INC. /DE/
- CIK
- CIK 818033
- Filed
- Oct 30, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership